Navigation Links
New Technology Reveals Proteins Responsible for Diseases

ate or regulate the same cellular process," explains Stagljar. "Identifying new interactors for ABC transporters may reveal unanticipated aspects of how these transporters function and help researchers gain clues for fighting disease and drug resistance."

Using iMYTH, the Stagljar lab identified six proteins that interact with and presumably communicate with the ABC transporter Ycf1p, a yeast version of the human proteins CFTR and MRP. These newly discovered protein interactors represent novel potential pharmaceutical targets. Through a series of biochemical and genetic tests, the researchers discovered that one of these interactors, Tus1p, regulates Ycf1p transporter function in a completely novel way to stimulate its ability to remove toxins from the cell.

"The more we learn about membrane proteins, the better we can use this knowledge for pharmacological and clinical applications," Stagljar says. "We work by putting together biochemical processes piece by piece like a puzzle. Hopefully soon we will have a complete picture of how many other diseases such as breast cancer, heart diseases, arthritis and schizophrenia are caused by mutations in various human membrane proteins."

Source-Eurekalert
'"/>




Page: 1 2

Related medicine news :

1. New Technology In MRI Scan Help Test Brain Cancer Therapy
2. Emergence Of New Gene Scanning Technology In Disease Research
3. Scientists Develop New Technology To Find About Human Ancestors’ Teet
4. Scientists Consider About New Technology Called Nanotechnology
5. Prostate Cancer Can Be Treated By Application Of LASER Technology
6. Georgia Institute of Technology develops doppler Vein finder
7. Novel Technology For Early Detection of Gastrointestinal Cancer
8. Winter Blues Treated by Breakthrough Lighting Technology
9. Bio-Technology Initiatives to Feed Research On Sorghum Crop
10. Technology Can Help Fight Health Care Costs
11. Technology at its nano best: hand-held lab-on-a-chip for blood tests
Post Your Comments:
(Date:5/12/2008)...AREMONT, Calif., May 12 /PRNewswire/ -- Keck Gradu...7, 2008, commencement ceremony will feature,the gr...es student, Eric,Tan, and the unveiling of KGI,s f...roud of Eric,s achievement in becoming the,first g...ewey, KGI,s senior,vice president for academic aff...
(Date:5/12/2008)...ake: VA Nurses Are ,the Compassionate Heart, of Sy.../ -- The Department of,Veterans Affairs (VA), the ... National Nurses Week by honoring six of its top p... heart of VA,s world-class health care,system," st...ake. "A great,deal of our reputation comes from th...
(Date:5/12/2008)... NASDAQ: CRME TSX: COM, VANCO...rma Corp.,(NASDAQ: CRME / TSX: COM) today announce...rst quarter of 2008 on the afternoon of Tuesday, M...all and webcast at 4:30pm,Eastern (1:30pm Pacific)...he conference call, please dial 416-641-6117 or,86...
(Date:5/12/2008)...s release is available in French . , Montreal,...shown that the administration of sildenafil protec...phy. This study was led by Dr. Christine Des Rosie...Heart Institute, in collaboration with Dr. Basil P...ersity Health Centre (MUHC) and Dr. Christian Desc...
Breaking Medicine News(10 mins):Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2Health News:Cardiome To Release 2008 First Quarter Results 2Health News:Cardiome To Release 2008 First Quarter Results 3Health News:Cardiome To Release 2008 First Quarter Results 4Health News:New approach to protect the hearts of patients with muscular dystrophy 2Health News:New approach to protect the hearts of patients with muscular dystrophy 3
...r rates of heart disease and cancer, although few ...ing out research into the effect of green tea in m... one of the many studies that will be done on the ...ss likely to have heart disease or cancer, althoug...
... a study on the agnus castus fruit, also known as ...en who took it had a 50 per cent or greater improv...nus castus (Vitex agnus castus) is a small tree na...ia. It has been used for ailments including haemo...
...pel Hill have found that giving x-rays to people ...ome. The study tracked two groups of patients - 42...x weeks. One group was given radiography, the othe...d that after three months, patients who had initia...
...hip between increasing rates of testicular cancer ...ho have infertility problems have an increased ris... of the British Medical Journal (BMJ), the study f... with infertility problems and the subsequent risk...
Other Medicine News:
(Date:5/12/2008)...timal Combination of Scaffolding, Deliverability a...L AVIV, Israel, May 12 /- Medinol is ... its Presillion(TM) CoCr Coronary Stent,enabling ... technologically,innovative flexible closed cell d... scaffolding the unprecedented,balance of flexibil...
(Date:5/12/2008)...Cohort 3 Demonstrated Improvement in T-Cell Respon...ential of HspE7, SAN DIEGO, May 12 /PRNewswire-Fi...(TSX: NVN) today announced positive immunological ...clinical trial of its lead product,candidate, HspE...asia, or,CIN, a precursor to cervical cancer. HPV ...
(Date:5/9/2008)...cine Studied in Patients Following Bunionectomy,...Many foot-surgery,patients experience intense pain...ne of the most common foot surgeries. The investig...icant relief for patients who had this,surgery, co...th tapentadol,also resulted in patients reporting ...
(Date:5/8/2008)... Renal Research Network Completes 13 Phase-I Clini...Late Stage Development, EL SEGUNDO, Calif., May 8..., a Phase I-IV clinical trial research service bus...e research and development for FDA approval,repor... and has another 34,active trials in late stage dr...
Breaking Medicine Technology:Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 5DaVita Clinical Research Completes Record Number of Renal Trials in 2007 2Jacobs Receives Contract for New Hospital Project in Belgium 952 1Jacobs Receives Contract for New Hospital Project in Belgium 952 2Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 487 1Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 487 2Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 487 3Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 487 4Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 487 5Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 487 6Enobia Pharma Raises 2440 1 Million Series B Financing 485 1Enobia Pharma Raises 2440 1 Million Series B Financing 485 2Primate behavior explained by computer agents 336 1Primate behavior explained by computer agents 336 2
...nce Call Scheduled for Friday, May 4, at 9:00 a.m....03, 2007 /PRNewswire-FirstCall/ --,Medivation, Inc...moderate subgroups of Alzheimer,s disease patients... of Dimebon showed that both,subgroups were improv...ive efficacy endpoints studied. , The mean drug-pl...
...gly Proves Functionality in Humans of CTI,s,Progra...ry Device -,ChronoDose, BASEL, Switzerland and TRE...erapeutics Inc. (CTI) announced today the successf...ial of its,programmable, pulsatile, passive transd...TM). CTI intends to publish this,clinical data in ...
Other Medicine Technology:Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device,Combination Product - ChronoDose 2Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device,Combination Product - ChronoDose 3
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: